CVRx, Inc. (CVRX)

CVRx, Inc. Investors Who Suffered Losses Should Contact Block & Leviton LLP

Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer

CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy

CVRx Eyes Barostim Growth as Coverage Gains and BENEFIT-HF Trial Launches

CVRx, Inc. (CVRX) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel Following Revenue Guidance Cut and Sales-Execution Disclosures

CVRx, Inc. (CVRX) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel Following Revenue Guidance Cut and Sales-Execution Disclosures

CVRx, Inc. (CVRX) Q2 2026 Earnings Call Transcript

CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates

CVRx Q2 Earnings Call Highlights

Compared to Estimates, CVRx (CVRX) Q2 Earnings: A Look at Key Metrics

CVRx Reports Second Quarter 2026 Financial and Operating Results